Ocugen Stock Discussion

$Ocugen (OCGN.US)$ good news out , les make alittle move up

$Ocugen (OCGN.US)$ Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
GlobeNewswire· 5 mins ago
OCU410 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reported, such as exudation, infectious endophthalmitis, intraocular Inflammation, anterior ischemic optic neuropathy, or vasculitis

$Ocugen (OCGN.US)$ just buy a bit. very few chances to get rich

$Ocugen (OCGN.US)$
Grabbed a few at .88. It usually hovers around $1-2, a little upside

$Ocugen (OCGN.US)$ i will buy when it drops more

$Ocugen (OCGN.US)$ buy abit

$Ocugen (OCGN.US)$ Reuters· 3 mins ago
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease

$Ocugen (OCGN.US)$ Reuters· just
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration